Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-Lasting T Cell Responses in BNT162b2 COVID-19 mRNA Vaccinees and COVID-19 Convalescent Patients
Antti Hurme, Pinja Jalkanen, Jemna Heroum, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection
Christina M. Arieta, Yushu Joy Xie, Daniel Rothenberg, et al.
Cell (2023) Vol. 186, Iss. 11, pp. 2392-2409.e21
Open Access | Times Cited: 57
An mpox virus mRNA-lipid nanoparticle vaccine confers protection against lethal orthopoxviral challenge
Alec W. Freyn, Caroline Atyeo, Patricia L. Earl, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 716
Closed Access | Times Cited: 54
Assessing the generation of tissue resident memory T cells by vaccines
E. Rotrosen, Thomas S. Kupper
Nature reviews. Immunology (2023) Vol. 23, Iss. 10, pp. 655-665
Open Access | Times Cited: 30
Multi-valent mRNA vaccines against monkeypox enveloped or mature viron surface antigens demonstrate robust immune response and neutralizing activity
Niubing Zhang, Xiang Cheng, Yilong Zhu, et al.
Science China Life Sciences (2023) Vol. 66, Iss. 10, pp. 2329-2341
Open Access | Times Cited: 27
Booster dose of SARS-CoV-2 messenger RNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: A prospective multicenter longitudinal study
Chiara Farroni, Alessandra Aiello, Andrea Picchianti Diamanti, et al.
International Journal of Infectious Diseases (2022) Vol. 125, pp. 195-208
Open Access | Times Cited: 32
Persistent T cell-mediated immune responses against Omicron variants after the third COVID-19 mRNA vaccine dose
Milja Belik, Oona Liedes, Saimi Vara, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
mRNA vaccine-induced SARS-CoV-2 spike-specific IFN-γ and IL-2 T-cell responses are predictive of serological neutralization and are transiently enhanced by pre-existing cross-reactive immunity
Philip Samaan, Chapin S. Korosec, Patrick Budylowski, et al.
Journal of Virology (2025)
Open Access
Intranasal recombinant protein subunit vaccine targeting TLR3 induces respiratory tract IgA and CD8 T cell responses and protects against respiratory virus infection
Katharina Wørzner, S. Schmidt, Julie Zimmermann, et al.
EBioMedicine (2025) Vol. 113, pp. 105615-105615
Open Access
Generating Self‐Adjuvated Nanofiber Vaccines by Coating Bacterial Flagella with Antigens
Zhenzhen Fu, Sisi Lin, Huan Chen, et al.
Advanced Materials (2025)
Open Access
Single-epitope T cell–based vaccine protects against SARS-CoV-2 infection in a preclinical animal model
Takuya Tada, Ju-Yi Peng, Belinda M. Dcosta, et al.
JCI Insight (2023) Vol. 8, Iss. 7
Open Access | Times Cited: 13
Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidence
David J. Bean, Janet Monroe, Yan Mei Liang, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 751
Open Access | Times Cited: 4
Humoral and cellular response induced by a second booster of an inactivated SARS-CoV-2 vaccine in adults
Constanza Méndez, Hernán F. Peñaloza, Bárbara M. Schultz, et al.
EBioMedicine (2023) Vol. 91, pp. 104563-104563
Open Access | Times Cited: 11
Identification of cross reactive T cell responses in adenovirus based COVID 19 vaccines
Joshua Gardner, Simon T. Abrams, Cheng‐Hock Toh, et al.
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 3
New insights into the pathogenesis of SARS-CoV-2 during and after the COVID-19 pandemic
Jonatan J. Carvajal, Valeria García-Castillo, Shelsy V. Cuellar, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
mRNA COVID-19 vaccine elicits potent adaptive immune response without the persistent inflammation seen in SARS-CoV-2 infection
Ellie Ivanova, Jasmine Shwetar, Joseph C. Devlin, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 25
mRNA COVID-19 vaccine elicits potent adaptive immune response without the acute inflammation of SARS-CoV-2 infection
Ellie Ivanova, Jasmine Shwetar, Joseph C. Devlin, et al.
iScience (2023) Vol. 26, Iss. 12, pp. 108572-108572
Open Access | Times Cited: 9
Humoral and cellular immune responses to CoronaVac up to one year after vaccination
Priscilla R. Costa, Carolina Argondizo Correia, Mariana Prado Marmorato, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 14
SARS-CoV-2 T Cell Immunity Responses following Natural Infection and Vaccination
Vassiliki Pitiriga, Myrto Papamentzelopoulou, Kanella E. Konstantinakou, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1186-1186
Open Access | Times Cited: 8
Five doses of the mRNA vaccination potentially suppress ancestral-strain stimulated SARS-CoV2-specific cellular immunity: a cohort study from the Fukushima vaccination community survey, Japan
Yuta Tani, Morihito Takita, Masatoshi Wakui, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Combining SARS‐CoV‐2 interferon‐gamma release assay with humoral response assessment to define immune memory profiles
William Mouton, Guy Oriol, Christelle Compagnon, et al.
European Journal of Immunology (2024) Vol. 54, Iss. 7
Closed Access | Times Cited: 2
A monkeypox mRNA-lipid nanoparticle vaccine targeting virus binding, entry, and transmission drives protection against lethal orthopoxviral challenge
Alec W. Freyn, Caroline Atyeo, Patricia L. Earl, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 13
COVID-19 vaccines and a perspective on Africa
Alberto Mantovani, María Rescigno, Guido Forni, et al.
Trends in Immunology (2023) Vol. 44, Iss. 3, pp. 172-187
Open Access | Times Cited: 7
Respiratory Viral Infections in Recipients of Cellular Therapies: A Review of Incidence, Outcomes, Treatment, and Prevention
Rita Wilson Dib, Ella Ariza‐Heredia, Amy Spallone, et al.
Open Forum Infectious Diseases (2023) Vol. 10, Iss. 4
Open Access | Times Cited: 7
Airway surveillance and lung viral control by memory T cells induced by COVID-19 mRNA vaccine
Brock Kingstad-Bakke, Thomas Cleven, Hailey E. Bussan, et al.
JCI Insight (2023) Vol. 8, Iss. 22
Open Access | Times Cited: 7
Worth a Pound of Cure? Emerging Strategies and Challenges in Cancer Immunoprevention
Saurav D. Haldar, Eduardo Vilar, Anirban Maitra, et al.
Cancer Prevention Research (2023) Vol. 16, Iss. 9, pp. 483-495
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top